PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:PHN - IT0005274094 - Common Stock
58.7 EUR
+0.2 (+0.34%)
Taking everything into account, PHN scores 7 out of 10 in our fundamental rating. PHN was compared to 14 industry peers in the Personal Care Products industry. PHN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PHN shows excellent growth, but is valued quite expensive already. These ratings could make PHN a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
Each year in the past 5 years PHN has been profitable.
Each year in the past 5 years PHN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 20.41%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 38.54%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 26.24%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHN had an Average Return On Invested Capital over the past 3 years of 17.21%. This is significantly above the industry average of 11.79%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(26.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROIC | 26.24% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN's Profit Margin of 13.48% is fine compared to the rest of the industry. PHN outperforms 78.57% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
PHN has a better Operating Margin (21.87%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
Looking at the Gross Margin, with a value of 97.04%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
PHN has about the same amout of shares outstanding than it did 1 year ago.
PHN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHN has an improved debt to assets ratio.
2.2 Solvency
PHN has an Altman-Z score of 9.98. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PHN (9.98) is better than 100.00% of its industry peers.
PHN has a debt to FCF ratio of 2.70. This is a good value and a sign of high solvency as PHN would need 2.70 years to pay back of all of its debts.
The Debt to FCF ratio of PHN (2.70) is better than 71.43% of its industry peers.
PHN has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
PHN has a Debt to Equity ratio of 0.28. This is in the better half of the industry: PHN outperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 9.98 |
ROIC/WACC3.33
WACC7.87%
2.3 Liquidity
PHN has a Current Ratio of 2.06. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.06, PHN belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
A Quick Ratio of 1.75 indicates that PHN should not have too much problems paying its short term obligations.
PHN has a Quick ratio of 1.75. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.20%, which is quite impressive.
PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 15.06% in the last year.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
3.2 Future
Based on estimates for the next years, PHN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.13% on average per year.
Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 13.74% on average per year.
EPS Next Y6.25%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
EPS Next 5YN/A
Revenue Next Year14.8%
Revenue Next 2Y14.39%
Revenue Next 3Y14.28%
Revenue Next 5Y13.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHN is valuated rather expensively with a Price/Earnings ratio of 23.96.
64.29% of the companies in the same industry are more expensive than PHN, based on the Price/Earnings ratio.
PHN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
A Price/Forward Earnings ratio of 24.04 indicates a rather expensive valuation of PHN.
PHN's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of PHN to the average of the S&P500 Index (23.92), we can say PHN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.96 | ||
| Fwd PE | 24.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHN is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
PHN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHN is more expensive than 78.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.37 | ||
| EV/EBITDA | 13.3 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
A more expensive valuation may be justified as PHN's earnings are expected to grow with 15.13% in the coming years.
PEG (NY)3.83
PEG (5Y)1.64
EPS Next 2Y13.31%
EPS Next 3Y15.13%
5. Dividend
5.1 Amount
PHN has a Yearly Dividend Yield of 1.76%.
PHN's Dividend Yield is comparable with the industry average which is at 2.19.
PHN's Dividend Yield is comparable with the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 40.63% of its income as dividend. This is a bit on the high side, but may be sustainable.
PHN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP40.63%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
BIT:PHN (1/12/2026, 9:07:11 AM)
58.7
+0.2 (+0.34%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners17.49%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap568.22M
Revenue(TTM)175.08M
Net Income(TTM)23.61M
Analysts82.86
Price Target82.62 (40.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.76% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP40.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.96 | ||
| Fwd PE | 24.04 | ||
| P/S | 3.25 | ||
| P/FCF | 69.37 | ||
| P/OCF | 46.1 | ||
| P/B | 9.28 | ||
| P/tB | 15.22 | ||
| EV/EBITDA | 13.3 |
EPS(TTM)2.45
EY4.17%
EPS(NY)2.44
Fwd EY4.16%
FCF(TTM)0.85
FCFY1.44%
OCF(TTM)1.27
OCFY2.17%
SpS18.09
BVpS6.33
TBVpS3.86
PEG (NY)3.83
PEG (5Y)1.64
Graham Number18.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.41% | ||
| ROE | 38.54% | ||
| ROCE | 45.24% | ||
| ROIC | 26.24% | ||
| ROICexc | 32.19% | ||
| ROICexgc | 49.25% | ||
| OM | 21.87% | ||
| PM (TTM) | 13.48% | ||
| GM | 97.04% | ||
| FCFM | 4.68% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexgc growth 3Y-15.98%
ROICexgc growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.7 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | 97.13% | ||
| Cap/Sales | 2.36% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.97% | ||
| Profit Quality | 34.7% | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 9.98 |
F-Score7
WACC7.87%
ROIC/WACC3.33
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.2%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%3.36%
EPS Next Y6.25%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
EPS Next 5YN/A
Revenue 1Y (TTM)15.06%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%10.35%
Revenue Next Year14.8%
Revenue Next 2Y14.39%
Revenue Next 3Y14.28%
Revenue Next 5Y13.74%
EBIT growth 1Y14.83%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year22.16%
EBIT Next 3Y18.62%
EBIT Next 5Y9.65%
FCF growth 1Y144.25%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y38.33%
OCF growth 3Y0.14%
OCF growth 5Y11.34%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
Can you provide the valuation status for PHARMANUTRA SPA?
ChartMill assigns a valuation rating of 2 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.
What is the profitability of PHN stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
How financially healthy is PHARMANUTRA SPA?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
Is the dividend of PHARMANUTRA SPA sustainable?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 5 / 10 and the dividend payout ratio is 40.63%.